206 related articles for article (PubMed ID: 14693716)
1. Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells.
Guo B; Koya D; Isono M; Sugimoto T; Kashiwagi A; Haneda M
Diabetes; 2004 Jan; 53(1):200-8. PubMed ID: 14693716
[TBL] [Abstract][Full Text] [Related]
2. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells.
Padilla J; Kaur K; Cao HJ; Smith TJ; Phipps RP
J Immunol; 2000 Dec; 165(12):6941-8. PubMed ID: 11120820
[TBL] [Abstract][Full Text] [Related]
4. Early stimulation and late inhibition of peroxisome proliferator-activated receptor gamma (PPAR gamma) gene expression by transforming growth factor beta in human aortic smooth muscle cells: role of early growth-response factor-1 (Egr-1), activator protein 1 (AP1) and Smads.
Fu M; Zhang J; Lin Y; Zhu X; Zhao L; Ahmad M; Ehrengruber MU; Chen YE
Biochem J; 2003 Mar; 370(Pt 3):1019-25. PubMed ID: 12457461
[TBL] [Abstract][Full Text] [Related]
5. PPAR-alpha ligands inhibit H2O2-mediated activation of transforming growth factor-beta1 in human mesangial cells.
Wilmer WA; Dixon CL; Hebert C; Lu L; Rovin BH
Antioxid Redox Signal; 2002 Dec; 4(6):877-84. PubMed ID: 12573136
[TBL] [Abstract][Full Text] [Related]
6. PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts.
Simonin MA; Bordji K; Boyault S; Bianchi A; Gouze E; Bécuwe P; Dauça M; Netter P; Terlain B
Am J Physiol Cell Physiol; 2002 Jan; 282(1):C125-33. PubMed ID: 11742805
[TBL] [Abstract][Full Text] [Related]
7. Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts.
Ferguson HE; Kulkarni A; Lehmann GM; Garcia-Bates TM; Thatcher TH; Huxlin KR; Phipps RP; Sime PJ
Am J Respir Cell Mol Biol; 2009 Dec; 41(6):722-30. PubMed ID: 19286977
[TBL] [Abstract][Full Text] [Related]
8. Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2.
Jung KM; Park KS; Oh JH; Jung SY; Yang KH; Song YS; Son DJ; Park YH; Yun YP; Lee MK; Oh KW; Hong JT
Mol Pharmacol; 2003 Mar; 63(3):607-16. PubMed ID: 12606768
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3.
Fu M; Zhang J; Zhu X; Myles DE; Willson TM; Liu X; Chen YE
J Biol Chem; 2001 Dec; 276(49):45888-94. PubMed ID: 11590167
[TBL] [Abstract][Full Text] [Related]
10. 15-Deoxy-Delta(12,14)-prostaglandin J(2) facilitates thyroglobulin production by cultured human thyrocytes.
Kasai K; Banba N; Hishinuma A; Matsumura M; Kakishita H; Matsumura M; Motohashi S; Sato N; Hattori Y
Am J Physiol Cell Physiol; 2000 Dec; 279(6):C1859-69. PubMed ID: 11078701
[TBL] [Abstract][Full Text] [Related]
11. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.
Galli A; Crabb DW; Ceni E; Salzano R; Mello T; Svegliati-Baroni G; Ridolfi F; Trozzi L; Surrenti C; Casini A
Gastroenterology; 2002 Jun; 122(7):1924-40. PubMed ID: 12055599
[TBL] [Abstract][Full Text] [Related]
13. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.
Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN
Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature.
Guan Y; Zhang Y; Schneider A; Davis L; Breyer RM; Breyer MD
Am J Physiol Renal Physiol; 2001 Dec; 281(6):F1036-46. PubMed ID: 11704554
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.
Wang M; Wise SC; Leff T; Su TZ
Diabetes; 1999 Feb; 48(2):254-60. PubMed ID: 10334298
[TBL] [Abstract][Full Text] [Related]
16. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a novel TGF-beta1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters.
Weigert C; Brodbeck K; Brosius FC; Huber M; Lehmann R; Friess U; Facchin S; Aulwurm S; Häring HU; Schleicher ED; Heilig CW
Diabetes; 2003 Feb; 52(2):527-35. PubMed ID: 12540631
[TBL] [Abstract][Full Text] [Related]
18. Effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on the expression of inflammatory cytokines and apoptosis induction in rheumatoid synovial fibroblasts and monocytes.
Ji JD; Cheon H; Jun JB; Choi SJ; Kim YR; Lee YH; Kim TH; Chae IJ; Song GG; Yoo DH; Kim SY; Sohn J
J Autoimmun; 2001 Nov; 17(3):215-21. PubMed ID: 11712859
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells.
Sugawara A; Takeuchi K; Uruno A; Ikeda Y; Arima S; Kudo M; Sato K; Taniyama Y; Ito S
Endocrinology; 2001 Jul; 142(7):3125-34. PubMed ID: 11416035
[TBL] [Abstract][Full Text] [Related]
20. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells.
Goetze S; Xi XP; Kawano H; Gotlibowski T; Fleck E; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 1999 May; 33(5):798-806. PubMed ID: 10226869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
